NEW YORK (Reuters Health) - Rifabutin-based triple therapy can eradicate Helicobacter pylori even in the face of resistance to clarithromycin or metronidazole, the ERADICATE Hp2 trial shows. "In the U ...

The US Food and Drug Administration (FDA) has approved two vonoprazan-based treatments for Helicobacter pylori infection: Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna ...

Background and Aims: The adjuvant effects of probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori (H. pylori) infection have not been evaluated. Methods: A total of 337 ...

The challenges posed in the treatment of Helicobacter pylori are increasing: falling rates of eradication and the rising prevalence of antibiotic-resistant H. pylori strains have led to a decline in ...

Bismuth quadruple therapy for 14 days is preferred regimen for treatment-naive patients when antibiotic susceptibility is unknown. William D. Chey, MD, from Michigan Medicine in Ann Arbor, and ...

The FDA approved two vonoprazan-based regimens, one with amoxicillin and clarithromycin (Voquezna Triple Pak), and one with amoxicillin (Voquezna Dual Pak), to treat Helicobacter pylori (H. pylori) ...

Increasing H pylori antibiotic resistance rates are affecting the efficacy of many traditional treatment options. 3-5 Therefore, alternative treatment options are being explored. To facilitate this ...

A new review published in the Cochrane Library, indicates that eradicating Helicobacter pylori bacterium-- the main cause of stomach ulcers - with a short course of therapy comprising two commonly ...

Talicia ® is the first and only FDA approved rifabutin-based H. pylori therapy and is designed to address the high and growing bacterial resistance and diminished efficacy of clarithromycin-based ...

It has been difficult to study the long-term effects of H pylori eradication alone on platelet response, as patients are usually on other treatments as well. In a new study from Korea, ITP patients in ...